Daniel O. Persky

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

Daniel O. Persky, Joseph M. Unger, Catherine Spier et al. · Journal of Clinical Oncology · 2008 · 292 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Jonathan W. Friedberg, Daruka Mahadevan, Erin Cebula et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Hematology, Pharmacology +17

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission

Daniel J. Landsburg, Marissa K. Falkiewicz, Joseph Maly et al. · Journal of Clinical Oncology · 2017 · 174 citations

Medicine, Oncology, Cell Therapy +11

Interactions of Elongation Factor 1α with F-Actin and β-Actin mRNA: Implications for Anchoring mRNA in Cell Protrusions

Gang Liu, Wayne Grant, Daniel O. Persky et al. · Molecular Biology of the Cell · 2002 · 172 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Lisa M. Rimsza, Michael LeBlanc, Joseph M. Unger et al. · Blood · 2008 · 141 citations · Full text

Medicine, Molecular Biology, Oncology +12